Abstract:Diabetic retinopathy (DR) is a leading cause of irreversible blindness in the working-age populations. Despite decades of research on the pathogenesis of DR for clinical care, a comprehensive understanding of the condition is still lacking due to the intricate cellular diversity and molecular heterogeneity involved. Single-cell RNA sequencing (scRNA-seq) has made the high-throughput molecular profiling of cells across modalities possible which has provided valuable insights into complex biological systems. In this review, we summarise the application of scRNA-seq in investigating the pathogenesis of DR, focusing on four aspects. These include the identification of differentially expressed genes, characterisation of key cell subpopulations and reconstruction of developmental 'trajectories' to unveil their state transition, exploration of complex cell-cell communication in DR and integration of scRNA-seq with genome-wide association studies to identify cell types that are most closely related to DR risk genetic loci. Finally, we discuss the future challenges and expectations associated with studying DR using scRNA-seq. We anticipate that scRNA-seq will facilitate the discovery of mechanisms and new treatment targets in the clinical care landscape for patients with DR.Key points Progress in scRNA-seq for diabetic retinopathy (DR) research includes studies on DR patients, non-human primates, and the prevalent mouse models. scRNA-seq facilitates the identification of differentially expressed genes, pivotal cell subpopulations, and complex cell-cell interactions in DR at single-cell level. Future scRNA-seq applications in DR should target specific patient subsets and integrate with single-cell and spatial multi-omics approaches. scRNA-seq provides novel insights into the pathogenesis of diabetic retinopathy, including identification of differentially expressed genes, characterisation of key cell subpopulations, construction of cell state transition trajectories and exploration of intricate cell-cell communication. image

In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy

Pathogenesis Study Based on High-Throughput Single-Cell Sequencing Analysis Reveals Novel Transcriptional Landscape and Heterogeneity of Retinal Cells in Type 2 Diabetic Mice

Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas

Single-cell combined transcriptional sequencing to explore key genes and regulatory mechanisms in diabetic retinopathy

Integrated Metabolomics and Transcriptomics Reveal Metabolic Patterns in Retina of STZ-Induced Diabetic Retinopathy Mouse Model

Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy

Multi-omics in exploring the pathophysiology of diabetic retinopathy

Single-cell RNA sequencing reveals the Müller subtypes and inner blood-retinal barrier regulatory network in early diabetic retinopathy

Integrated Bioinformatic Changes and Analysis of Retina with Time in Diabetic Rats

Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy

Single-cell RNA sequencing reveals the Muller subtypes and inner blood-retinal barrier regulatory network in early diabetic retinopathy

Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning

Studies of the Retinal Microcirculation Using Human Donor Eyes and High-Resolution Clinical Imaging: Insights Gained to Guide Future Research in Diabetic Retinopathy

Identifying Gene Variants Underlying the Pathogenesis of Diabetic Retinopathy Based on Integrated Genomic and Transcriptomic Analysis of Clinical Extreme Phenotypes.

Identification of Immune Associated Potential Molecular Targets in Proliferative Diabetic Retinopathy

Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip

The integrated transcriptome bioinformatics analysis identifies key genes and cellular components for proliferative diabetic retinopathy

Identification of novel key molecular signatures in the pathogenesis of experimental diabetic retinopathy

Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy

Roles of noncoding RNAs in diabetic retinopathy: Mechanisms and therapeutic implications

Diabetic retinopathy: Involved cells, biomarkers, and treatments